Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT 2 TO FORM S-1 - Dicerna Pharmaceuticals Inc | d622509ds1a.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Amendment No. 2 to Registration Statement No. 333-193150 of our report dated November 8, 2013, relating to the financial statements of Dicerna Pharmaceuticals, Inc. appearing in the Prospectus, which is a part of such Registration Statement, and to the reference to us under the heading “Experts” in such Prospectus.
/s/ Deloitte & Touche LLP
Boston, Massachusetts
January 21, 2014